Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanochemical Endovenous Ablation (MOCA) Versus RADiofrequeNcy Ablation (RFA) in the Treatment of Primary Great Saphenous Varicose Veins: a Multicentre Randomized Trial

NCT01936168 is registered in ClinicalTrials.gov with Rijnstate Hospital as lead sponsor.

NCT NCT01936168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01936168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanochemical Endovenous Ablation (MOCA) Versus RADiofrequeNcy Ablation (RFA) in the Treatment of Primary Great Saphenous Varicose Veins: a Multicentre Randomized Trial
Lead sponsor
Rijnstate Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2016
Completion date
December 31, 2020
Enrollment
213 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

greater saphenous vein injury